Literature DB >> 3321448

Therapy-related leukemia and myelodysplastic syndrome.

H M Kantarjian1, M J Keating.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3321448

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  7 in total

1.  Synergistic action of the benzene metabolite hydroquinone on myelopoietic stimulating activity of granulocyte/macrophage colony-stimulating factor in vitro.

Authors:  R D Irons; W S Stillman; D B Colagiovanni; V A Henry
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

2.  Acute leukemia associated with mediastinal germ cell tumor. De novo versus therapy-related leukemia.

Authors:  Y K Keung; R Liang; E K Chiu
Journal:  West J Med       Date:  1993-04

Review 3.  Complications of cyclophosphamide therapy.

Authors:  C A Langford
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

4.  Therapy-related myelodysplastic syndrome in children with medulloblastoma following MOPP chemotherapy.

Authors:  A Hayani; D H Mahoney; L D Taylor
Journal:  J Neurooncol       Date:  1992-09       Impact factor: 4.130

Review 5.  Development of radioimmunotherapy for the treatment of non-Hodgkin's lymphoma.

Authors:  P Multani
Journal:  Int J Hematol       Date:  2002-12       Impact factor: 2.490

6.  Heavy-chain immunoglobulin gene rearrangement and cytoplasmic immunoglobulin expression in acute monocytic leukemia following primary germ cell tumor.

Authors:  H T Greinix; C Beham-Schmid; H Silly; G Hoefler; A Kasparek; H L Seewann
Journal:  Ann Hematol       Date:  1995-02       Impact factor: 3.673

7.  Incidence of myelodysplastic syndrome in Japan.

Authors:  Dai Chihara; Hidemi Ito; Kota Katanoda; Akiko Shibata; Tomohiro Matsuda; Tomotaka Sobue; Keitaro Matsuo
Journal:  J Epidemiol       Date:  2014-08-02       Impact factor: 3.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.